Search results

Page results

• Robotic surgery for bladder cancer improves patient recovery time

  Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a trial led by UCLH, UCL and the University of Sheffield.

• New surgical technique preserves continence in men after prostate removal

  A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.

• Peripherally inserted central catheters (PICCs)

  This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).

• Meet Matthew and Lillyanne

  Matthew Fielden and Lillyanne Tran volunteer in the cognitive disorders outpatients’ clinic at the National Hospital for Neurology and Neurosurgery.

• CQC inspection again rates UCLH maternity as ‘Good’.

  The Elizabeth Garrett Anderson maternity service at UCLH has been rated ‘Good’ following an inspection by the Care Quality Commission (CQC) in June 2023.

• App detecting neonatal jaundice from the eye successful in first major clinical trial

  A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.

• Hydrogen / methane breath test for fructose / lactose malabsorption – Face-to-face testing

  This page is for patients who are doing a face-to-face breath test in the hospital to test for either fructose or lactose malabsorption.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• Cancer immunotherapy treatment

  This page is for cancer patients receiving immunotherapy treatment.

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.